Nanjing Vazyme Biotech Co., Ltd.SSE: 688105

Earnings Preannouncement for 2025

Jan 30, 2026 · Issued by Nanjing Vazyme Biotech Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 30, 2026

On 6ix: 6ix.com/news/earnings-preannouncement-for-2025-258

Earnings Preannouncement for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Nanjing Vazyme Biotech Co., Ltd. on 6ix

Earlier from Nanjing Vazyme Biotech

Announcement on Expiration of Shareholding Reduction Plan and Results of ShareholdersDec 25, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% ScaleDec 23, 2025
Announcement on Voluntary Disclosure of Obtaining EU CE IVDR Certification for the Company's ProductsDec 18, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Dec 6, 2025
Announcement on Election of Employee DirectorNov 21, 2025

Later from Nanjing Vazyme Biotech

Announcement on Estimated Daily Related Party Transactions in 2026Feb 12
Announcement on Preliminary Earnings Estimate for 2025Feb 27
Announcement on Progress in Repurchasing Shares through Call AuctionMar 3
Announcement on Implementation Result of Shares Repurchase and Share ChangesApr 3
Announcement on Resolutions of the 22nd Meeting of the 2nd Board of DirectorsApr 23

All Nanjing Vazyme Biotech news releases

Follow Nanjing Vazyme Biotech into a list and get an email when it puts out news.

Follow Nanjing Vazyme Biotech